Endoscopic treatment of vesicoureteral reflux: Current status
Vesicoureteral reflux (VUR) affects around 1% of all children. It carries an increased risk of febrile urinary tract infections (UTIs) and is associated with impaired renal function. Endoscopic treatment with NASHA/Dx gel (dextranomer microspheres in a stabilized hyaluronic acid-based gel of nonanim...
Main Author: | Goran Lackgren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2009-01-01
|
Series: | Indian Journal of Urology |
Subjects: | |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2009;volume=25;issue=1;spage=34;epage=39;aulast=Lackgren |
Similar Items
-
Efficiency of endoscopic treatment compared to open surgical management of the vesicoureteral reflux
by: Mugabe Herbert, et al.
Published: (2018-01-01) -
Vesicoureteral reflux
by: Jia-Hwia Wang
Published: (2014-06-01) -
Treatment Outcomes of Subureteric Injection and Ureteroneocystostomy in Children with Vesicoureteral Reflux
by: Serkan Arslan, et al.
Published: (2016-06-01) -
Endoscopic Management of Complicated Highgrade Vesicoureteral Reflux in the First Year of Life
by: Ali Tekin, et al.
Published: (2021-09-01) -
VESICOURETERAL REFLUX SCREENING IN SIBLINGS OF PATIENTS WITH KNOWN REFLUX
by: N. Ataei, et al.
Published: (2003-08-01)